STOCKHOLDER ALERT: Kaskela Law LLC Announces Investigation of Rafael Holdings, Inc. and Encourages Stockholders to Contact the Firm - RFL

June 28, 2021 2:00 PM EDT | Source: Kaskela Law LLC

Philadelphia, Pennsylvania--(Newsfile Corp. - June 28, 2021) - Kaskela Law LLC announces that it is investigating Rafael Holdings, Inc. ("Rafael Holdings") (NYSE: RFL) on behalf of the company's stockholders.

On June 21, 2021, Rafael Holdings announced that it had entered into an agreement to acquire Rafael Pharmaceuticals, Inc. ("Pharmaceuticals") in an all-stock transaction. According to the announcement, Pharmaceuticals' stockholders will receive shares of Rafael Holdings' common stock "amounting to approximately 48% of the currently outstanding capitalization of the company."

The investigation seeks to determine whether Rafael Holdings and/or the company's officers and directors violated the securities laws or breached their fiduciary duties to stockholders in connection with the proposed agreement to acquire Pharmaceuticals.

Rafael Holdings' stockholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq.) at (484) 258 - 1585, or by email at or online at, for additional information about this investigation and their legal rights and options.

Kaskela Law LLC represents investors in securities fraud, corporate governance, and merger & acquisition litigation. For additional information about Kaskela Law LLC please visit This notice may constitute attorney advertising in certain jurisdictions.

David Seamus Kaskela, Esq.

18 Campus Boulevard, Suite 100
Newtown Square, PA 19073
(484) 258 - 1585
(888) 715 - 1740

To view the source version of this press release, please visit